New Genetics and Society

Papers
(The median citation count of New Genetics and Society is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Genome editing: the dynamics of continuity, convergence, and change in the engineering of life19
I am a Viking! DNA, popular culture and the construction of geneticized identity17
A cold yield. Cryopreserved oocytes of “social freezing” customers as potential option values for biomedical research13
Problematizing consent: searching genetic genealogy databases for law enforcement purposes12
Thinking the unthinkable: how did human germline genome editing become ethically acceptable?12
Transparency, consent and trust in the use of customers' data by an online genetic testing company: an Exploratory survey among 23andMe users10
Beyond nosology? Molecular tumor boards, singularization, and the conflation of diagnosis and therapy10
Long-range familial searches in recreational DNA databases: expansion of affected populations, the participatory turn, and the co-production of biovalue9
The consumer representation of DNA ancestry testing on YouTube9
Opening up forensic DNA phenotyping: the logics of accuracy, commonality and valuing9
The omics of our lives: practices and policies of direct-to-consumer epigenetic and microbiomic testing companies8
The welfare state driving “me” and “we” medicine – a critical discourse analysis8
Decision-making about non-invasive prenatal testing: women’s moral reasoning in the absence of a risk of miscarriage in Germany8
Organizing precision oncology: introduction to the special issue7
The somatic mode: doing good in targeted cancer therapy7
Past-futures in experimental care: breast cancer and HIV medicine7
Genetic ancestry testing, whiteness and the limits of anti-racism6
The platforming of human embryo editing: prospecting “disease free” futures6
A feeling for the (micro)organism? Yeastiness, organism agnosticism and whole genome synthesis6
Data curation-research: practices of data standardization and exploration in a precision medicine database5
Putting menopause on ice: the cryomedicalization of reproductive aging5
Organizing the precision clinic: arranging expertise, knowledge and technologies in cancer precision medicine clinical trials5
The social shaping of a diagnosis in Next Generation Sequencing5
Beyond full jurisdiction: pathology and inter-professional relations in precision medicine5
The rise of the biocyborg: synthetic biology, artificial chimerism and human enhancement4
Embodied material encounters and the ambiguous promise of biomedical futures: The case of biologically derived medicines4
Promising precision medicine: how patients, clinicians and caregivers work to realize the potential of genomics-informed cancer care4
The new stage of public engagement with science in the digital media environment: citizen science communicators in the discussion of GMOs on Zhihu4
Accessing targeted therapies for cancer: self and collective advocacy alongside and beyond mainstream cancer charities4
Expanding the notion of “benefit”: comparing public, parent, and professional attitudes towards whole genome sequencing in newborns4
Applying a risk governance approach to examine how professionals perceive the benefits and risks of clinical genomics in Australian healthcare3
“If relatives inherited the gene, they should inherit the data.” Bringing the family into the room where bioethics happens3
Frozen: social and bioethical aspects of cryopreservation3
“Donating with eyes shut”: attitudes regarding DNA donation to a large-scale biobank in Israel3
Assessing public opinions on the likelihood and permissibility of gene editing through construal level theory3
Governing expectations of forensic innovations in society: the case of FDP in Germany2
Environmental sustainability and biobanking: a pilot study of the field2
Epistemic dwelling: precision immuno-oncology by design2
“We are all cousins.” Belgian ancestry and genomic testing in a close-knit community in Northeastern Wisconsin2
“It’s personalized, but it’s still bucket based”: the promise of personalized medicine vs. the reality of genomic risk stratification in a breast cancer screening trial2
Reinterpreting “genetic identity” in the regulatory and ethical context of heritable genome editing2
Editorial: themed issue: understanding the technical and social landscape of gene editing2
Gene drive communication: exploring experts’ lived experience of metaphor use1
Intrinsic responsible innovation in a synthetic biology research project1
The unexpected and unanticipated announcement of the “world’s first” gene edited babies: breaching, repairing and strengthening community boundaries1
Translating cell biology of ageing? On the importance of choreographing knowledge1
The challenge of recruiting diverse populations into health research: an embedded social science perspective1
“It didn’t mean anything” – moving within a landscape of knowledge to interpret genetics and genetic test results within familial cancer concerns1
Biotechnologies in pest wasp control: taking the sting out of pest management for Māori businesses?1
Māori views of forensic DNA evidence: an instrument of justice or criminalizing technology?1
Navigating narratives of genetic categorization at the frayed edges of identity1
Consensus too soon: judges’ and lawyers’ views on genetic information use1
Sequencing BGI: the evolution of expertise and research organisation in the world’s leading gene sequencing facility1
“Idealists and capitalists”: ownership attitudes and preferences in genomic citizen science1
The pathos of precision1
0.016008138656616